Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years of age and older;
Have a diagnosis of of rheumatoid arthritis (ICD-9:714x.xx);
Have been enrolled for at least 6 months for the 6 months assessment and 12 months for the 12 months assessment;
are enrolled in a health plan between February 2006 and June 2009
have claims indicating at least one use of either abatacept, etanercept, adalimumab or infliximab for at least 6 months for teh 6 months assessment and 12 months for the 12 months assessment
You may not be if
Patients not continuously eligible for health plan benefits for the same evaluation periods will be excluded
Patients who are on other biologics in the 6 and 12 month post-index period will be excluded (ex. those in the abatacept cohort will be excluded if they also have claims for etanercept in the 6 and 12 month post-index period).
Patients on biologics 6 months prior to the biologic index date will also be excluded
Patients with diagnosis for other non-RA conditions commonly treated with biologics (ex. Crohn's disease) during the 6 month pre-index period.
